SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013051
Filing Date
2022-05-12
Accepted
2022-05-12 16:27:45
Documents
80
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1254814
2 ex-31.htm EX-31 33897
3 ex-32.htm EX-32 8501
  Complete submission text file 0001493152-22-013051.txt   7958637

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocx-20220331.xsd EX-101.SCH 75352
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocx-20220331_cal.xml EX-101.CAL 68459
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocx-20220331_def.xml EX-101.DEF 360134
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocx-20220331_lab.xml EX-101.LAB 558930
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocx-20220331_pre.xml EX-101.PRE 468601
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1273425
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 22918267
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences